Clinical trial
Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System
NCT04982406 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 18, 2021
- Completion date
- January 21, 2025
- Enrollment
- 409 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis, heart block, transcatheter aortic valve replacement